Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression.
about
Glycogen synthase kinase 3: more than a namesakeGSK-3: tricks of the trade for a multi-tasking kinaseStearoyl-CoA desaturase 1 deficiency elevates insulin-signaling components and down-regulates protein-tyrosine phosphatase 1B in muscleGlycogen synthase kinase-3 regulates IGFBP-1 gene transcription through the thymine-rich insulin response elementPancreatic regulation of glucose homeostasisGlycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and ImagingAdaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous systemInsulin regulation of hepatic insulin-like growth factor-binding protein-1 (IGFBP-1) gene expression and mammalian target of rapamycin (mTOR) signalling is impaired by the presence of hydrogen peroxideInsulin regulation of insulin-like growth factor-binding protein-1 gene expression is dependent on the mammalian target of rapamycin, but independent of ribosomal S6 kinase activityGlycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithiumFunctional characterisation of the regulation of CAAT enhancer binding protein alpha by GSK-3 phosphorylation of Threonines 222/226.GSK-3 inhibitors induce chromosome instability.RNAi screening for kinases and phosphatases identifies FoxO regulatorsGerm band retraction as a landmark in glucose metabolism during Aedes aegypti embryogenesisHepatic Bax inhibitor-1 inhibits IRE1alpha and protects from obesity-associated insulin resistance and glucose intolerance.A time-series DDP for functional proteomics profilesDynamic modulation of innate immune response by varying dosages of lipopolysaccharide (LPS) in human monocytic cells.Glycogen synthase kinase 3β (GSK3β) modulates antiviral activity of zinc-finger antiviral protein (ZAP).GSK3 takes centre stage more than 20 years after its discovery.GSK3β-dependent inhibition of AMPK potentiates activation of neutrophils and macrophages and enhances severity of acute lung injury.New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c.Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation.Innate immune programing by endotoxin and its pathological consequencesWhat Are the bona fide GSK3 Substrates?Challenges and opportunities with glycogen synthase kinase-3 inhibitors for insulin resistance and Type 2 diabetes treatment.Novel concepts in insulin regulation of hepatic gluconeogenesis.Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders.Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword?EGFR Signal-Network Reconstruction Demonstrates Metabolic Crosstalk in EMT.Inhibition of GSK-3beta as a target for cardioprotection: the importance of timing, location, duration and degree of inhibition.Hepatitis C virus NS5A promotes insulin resistance through IRS-1 serine phosphorylation and increased gluconeogenesis.Targeting glycogen synthase kinase-3 in insulin signalling.Transcriptional regulation by insulin: from the receptor to the gene.PfIRR Interacts with HrIGF-I and Activates the MAP-kinase and PI3-kinase Signaling Pathways to Regulate Glycogen Metabolism in Pinctada fucata.Tissue-specific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action.Anaesthesia generates neuronal insulin resistance by inducing hypothermiaThe marine natural-derived inhibitors of glycogen synthase kinase-3beta phenylmethylene hydantoins: In vitro and in vivo activities and pharmacophore modeling.Review of lithium effects on brain and blood.Testosterone supplementation improves glucose homeostasis despite increasing hepatic insulin resistance in male mouse model of type 2 diabetes mellitus.Tau as a therapeutic target for Alzheimer's disease
P2860
Q24315635-CB4B82AE-C24F-49C8-81DA-A94A02248C66Q24624069-BDC579E9-C324-4E46-A5DF-3ED81E683101Q24685655-6A0138DB-DED2-45D4-A264-2FB02902BF2DQ24793511-F20B3466-6A8A-49B4-A66B-0E42BFC496F5Q26766485-1FD45788-8E08-49EA-AEB4-E8B915A5277FQ26768475-9FCF4C39-EF87-43B7-B8BE-1D5E3EB71660Q28389419-89674B43-F86C-4568-85B2-46F577BE58C0Q28565901-8F351A25-ED93-4070-A728-4C4682B70BBFQ28574617-423F77E0-D16A-4473-BF97-4F7C578DCEC1Q30362607-D369CCDB-3F73-4001-A535-FA2A4069DBBDQ33239129-1EDE65ED-0551-4D6F-A3C1-5C3E398D813CQ33294105-D8CB847D-6D5D-4E71-9372-1E5991C60AC8Q33371685-541A5A58-9945-47C3-BCA7-4B8908D0B683Q33534467-B183CFDF-80A3-4A52-81E6-155867F8409DQ33673551-0FD73D7F-DA9F-4642-8E52-197A528E1339Q33880709-1344155C-B8F4-4D07-A799-A171026A06FFQ33985344-8CC3A7B4-7E39-4A4F-9AA1-EF27BAA82DFBQ34238255-964A1A2E-0C22-484C-A27C-67CB7555D9FBQ34374129-61F47995-1447-4327-AA65-BA922CE9E8CEQ34519373-358DA7A5-E3E1-4FE0-8825-802DC1A2A26EQ34682304-E31762E3-DD1A-40A2-9350-2A623717B1ADQ34732988-2457E282-4B5E-4491-8186-BEC1877749B4Q34841012-CB011C55-7C35-4CEF-A96F-6DB062DF9C4AQ35001234-A252EFC9-B2F9-44F1-B276-B8F59C8A1747Q35207622-50E39890-580F-4B33-B913-CF7EC017A194Q35213690-04F7E423-979B-46F1-97B1-889A1A0C66E1Q35610595-11178B38-605C-4837-B7B1-721DDD09821FQ35922886-9059F3D7-918F-43A2-87BC-61B47D9C18B6Q36037821-C823317A-D0A7-4AB8-A09B-9A1F5AE21A1CQ36158687-DFCD54C6-EF06-4BB3-952A-56E2183C8F5DQ36290384-25B81CCC-9C84-4C19-867D-662BDD75B25EQ36481069-D8E59A97-A581-4377-8F86-9EB93EDCE048Q36602626-8C70F175-16B0-4254-AC7E-89F38A3D1EC4Q36615974-77318CBE-9D19-43D0-8BFC-4B1325E29803Q36959923-F7E6F95B-C2C2-426C-A021-18DCD84122E7Q36980453-C66C3DF8-C046-4C84-8A2A-1799EC689FF4Q37345648-4F65AA78-413E-456E-95F7-F1C035E2538DQ37517959-48AA4006-96D2-49A2-8EEF-17C633193DE0Q37575890-F19AE695-46CC-4F8F-A767-FFD1451DF80AQ37890451-D8CEC08F-3305-4D8A-B38B-416EE9476BAC
P2860
Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Inhibition of GSK-3 selectivel ...... carboxykinase gene expression.
@ast
Inhibition of GSK-3 selectivel ...... carboxykinase gene expression.
@en
type
label
Inhibition of GSK-3 selectivel ...... carboxykinase gene expression.
@ast
Inhibition of GSK-3 selectivel ...... carboxykinase gene expression.
@en
prefLabel
Inhibition of GSK-3 selectivel ...... carboxykinase gene expression.
@ast
Inhibition of GSK-3 selectivel ...... carboxykinase gene expression.
@en
P2093
P1433
P1476
Inhibition of GSK-3 selectivel ...... carboxykinase gene expression.
@en
P2093
C Sutherland
P A Lochhead
P304
P356
10.2337/DIABETES.50.5.937
P407
P577
2001-05-01T00:00:00Z